Three new triple quads achieve a new global standard in mass spectrometry - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Three new triple quads achieve a new global standard in mass spectrometry

Three new triple quadrupole mass spectrometers LCMS-8040, LCMS-8080 and GCMS-TQ8030 complete Shimadzu’s UFMS series consisting of seven powerful systems. The UFMS product family provides higher sensitivity, greater excellence in data quality, increased analytical throughput and a wider range of applications.

The new LCMS-8040 and LCMS-8080 expand the analytical range of Shimadzu’s LC-MS/MS lineup while the GCMS-TQ8030 achieves new levels of speed and sensitivity in GCMS analysis.

GCMS-TQ8030 - ultra-fast analysis meets sensitivity and accuracy
The GCMS-TQ8030 achieves the highest sensitivity in its class for multiple reaction monitoring (MRM) measurements based on UFsweeper® technology. Superior mass spectra and sensitivity at high scan speeds of up to 20,000 masses/sec is achieved using Advanced Scanning Speed Protocol (ASSP™).

The GCMS-TQ8030’s ecology mode reduces carbon dioxide emissions through a reduction of power consumption in analysis standby mode of 36 percent while also decreasing the consumption of carrier gas.

LCMS-8040 - Expanded range of ultra-fast, high-sensitivity applications
The system combines newly improved ion optics and collision cell technology with proprietary ultrafast technologies. This significantly expands the application range and ensures high-sensitivity, high-throughput analysis at lower levels of detection. A five-fold increase in sensitivity (reserpine, S/N ratio) has been achieved when compared with the LCMS-8030 model.

The LCMS-8040 is the world’s fastest LCMS/MS tandem mass spectrometer and provides multiple reaction monitoring (MRM) transition speeds of up to 555 MRMs per second. This is based on UFsweeper® II collision cell technology that maintains sensitivity and suppresses cross-talk, even for high-speed or simultaneous multi-component analyses.

LCMS-8080 - LC/MS/MS trace analysis of compounds in complex matrices
The LCMS-8080 LC/MS/MS provides outstanding sensitivity with a large dynamic range and quantitation performance. Combined with the reliable and well-established Shimadzu HPLC / UFLC front end systems already known as the fastest systems with lowest carry-over market-wide, it is the perfect solution for highly sensitive detection and quantification of compounds in complex matrices.

Its best-in-class sensitivity is based on technologies such as Coaxial Hot Gas which provides efficient ionization, while HSID (Hot Source Induced Desolvation) removes neutral contaminants and ensures reliable introduction of the ions into the mass spectrometer.

For more information please visit www.shimadzu.eu.

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search

Click here